Audience -All Patients & Families-Adults & Aging-Chapters-Donors & Supporters-Healthcare Providers-Kids & Young Adults-Men-Payers-Spanish Speaking Individuals-Undiagnosed-Women & Girls Type of Bleeding Disorder -All Bleeding Disorders-Hemophilia-Inhibitors-Rare Bleeding Disorders-Von Willebrand Disease Topic -Advocacy-Awareness-Blood & Product Safety-Bone & Joint Health-Community-COVID-19-Digital Health-Diversity, Equity & Inclusion-Fitness & Nutrition-Future Therapies-Health Equity-Healthcare Insurance-HIV & Hepatitis C-Mental Health-Pain Management-Sexual & Reproductive Health-Research-Treatment & Care 16 Mar Breakthrough Bleeding Episodes in Pediatric Severe Hemophilia a Patients with and without Inhibitors Receiving Emicizumab Prophylaxis: a Single-center Retrospective Review Mar 16, 2022 09 Mar Hepatitis C Virus in Hemophilia: Health-related Quality of Life After Successful Treatment Mar 9, 2022 23 Feb Rare Bleeding Disorders in the Plains Community Feb 23, 2022 - Feb 23, 2022 16 Feb Point of Care Coagulation Testing Using ClotChip Technology Feb 16, 2022 - Feb 16, 2022 09 Feb Advocating for Your Care in the Emergency Room Feb 9, 2022 - Feb 9, 2022 02 Feb Applications of Gene Editing in Medical Science Feb 2, 2022 - Feb 2, 2022 26 Jan NHF Fellowship and Grant Application Information Session Jan 26, 2022 - Jan 26, 2022 19 Jan Evaluation of Sexual Health in People with Hemophilia Jan 19, 2022 - Jan 19, 2022 12 Jan New Hemophilia Treatments: Implications for the Coagulation Laboratory Jan 12, 2022 - Jan 12, 2022 05 Jan Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations Jan 5, 2022 - Jan 5, 2022 15 Dec 2021 Recap and the Year Ahead Dec 15, 2021 - Dec 15, 2021 08 Dec VWF Regulation in Blood Outgrowth Endothelial Cells Dec 8, 2021 - Dec 8, 2021 01 Dec Spots, Dots, and Clots Clinic: A designated combined hematology/reproductive medicine clinic at OHSU Dec 1, 2021 - Dec 1, 2021 17 Nov Navigating Time and Space: Experiences of Aging with Hemophilia Nov 17, 2021 10 Nov The Science of Pain Nov 10, 2021 03 Nov Advocacy Update from NHF Nov 3, 2021 27 Oct Platelet Derived Factor VIII: A Different Approach to Gene Therapy Oct 27, 2021 - Oct 27, 2021 20 Oct Monitoring the Coagulation Status of People with Hemophilia Receiving Emicizumab Oct 20, 2021 - Oct 20, 2021 13 Oct NHF & WFH: A Continued Partnership Oct 13, 2021 - Oct 13, 2021 06 Oct NIH UNITE Initiative to End Structural Racism Oct 6, 2021 - Oct 6, 2021 22 Sep Is Pharmacokinetic Assessment a Step Towards Precision Medicine? Sep 22, 2021 - Sep 22, 2021 08 Sep Anti-TFPI for the Treatment of People with Hemophilia Sep 8, 2021 - Sep 8, 2021 01 Sep Gene Therapy for Inheritable Bleeding Disorders Sep 1, 2021 - Sep 1, 2021 11 Aug State of the Science Update and What to Expect - Part 2 Aug 11, 2021 - Aug 11, 2021 Pagination First page Previous page Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Next page Last page
16 Mar Breakthrough Bleeding Episodes in Pediatric Severe Hemophilia a Patients with and without Inhibitors Receiving Emicizumab Prophylaxis: a Single-center Retrospective Review Mar 16, 2022
09 Mar Hepatitis C Virus in Hemophilia: Health-related Quality of Life After Successful Treatment Mar 9, 2022
12 Jan New Hemophilia Treatments: Implications for the Coagulation Laboratory Jan 12, 2022 - Jan 12, 2022
05 Jan Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations Jan 5, 2022 - Jan 5, 2022
01 Dec Spots, Dots, and Clots Clinic: A designated combined hematology/reproductive medicine clinic at OHSU Dec 1, 2021 - Dec 1, 2021
27 Oct Platelet Derived Factor VIII: A Different Approach to Gene Therapy Oct 27, 2021 - Oct 27, 2021
20 Oct Monitoring the Coagulation Status of People with Hemophilia Receiving Emicizumab Oct 20, 2021 - Oct 20, 2021
